Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 493.00
-11.85 (-2.35%)
May 27, 2026, 3:30 PM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 96.26 billion as of May 28, 2026. Its market cap has increased by 73.92% in one year.
Market Cap
96.26B
Enterprise Value
102.40B
Revenue
15.49B
Ranking
n/a
PE Ratio
39.56
Stock Price
493.00
Market Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 96.26B, an increase of 213,339.29%. That is a compound annual growth rate of 33.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 96.26B | 53.22% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NATCO Pharma | 210.60B |
| Eris Lifesciences | 187.14B |
| Cohance Lifesciences | 166.38B |
| Alembic Pharmaceuticals | 148.25B |
| Alivus Life Sciences | 131.36B |
| Strides Pharma Science | 106.40B |
| Akums Drugs and Pharmaceuticals | 81.95B |
| Sudeep Pharma | 76.21B |